Form 4 Adaptive Biotechnologies For: Oct 06 Filed by: BOBULSKY SUSAN
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 LENNAR CORP /NEW/ For: Oct 07 Filed by: OLIVERA ARMANDO J
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 LENNAR CORP /NEW/ For: Oct 07 Filed by: SONNENFELD JEFFREY
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form S-1MEF Retension Pharmaceutical
As filed with the Securities and Exchange Commission on October 8, 2026
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
RETENSION PHARMACEUTICALS, INC.
(Exact name of Registrant as specified in its charter)
Delaware 2834 ... (continue reading...)
Form 4 MGM Resorts Internationa For: Oct 07 Filed by: Fritz Gary M
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
More SEC Filings
View Older Stories-
Form 4 Skydance Corp For: Oct 06 Filed by: Jobs Laurene Powell
-
Form 4 MGM Resorts Internationa For: Oct 07 Filed by: Halkyard Jonathan S
-
Form 4 LENNAR CORP /NEW/ For: Oct 07 Filed by: HUDSON SHERRILL W
-
Form 4 MGM Resorts Internationa For: Oct 07 Filed by: HORNBUCKLE WILLIAM
-
Form 4 LENNAR CORP /NEW/ For: Oct 07 Filed by: Smith Dacona
-
Form SCHEDULE 13D/A ArriVent BioPharma, Inc. Filed by: ORBIMED ADVISORS LLC
-
Form 3 Retension Pharmaceutical For: Oct 08 Filed by: Schwartz Alexander Duke
-
Form 4 MGM Resorts Internationa For: Oct 07 Filed by: McManus John
-
Form 3 Retension Pharmaceutical For: Oct 08 Filed by: Sweetnam Paul
-
Form 3 Skydance Corp For: Oct 06 Filed by: Jobs Laurene Powell
-
Form 3 Retension Pharmaceutical For: Oct 08 Filed by: Schecter Alison D.
-
Form 4 LENNAR CORP /NEW/ For: Oct 07 Filed by: Wolfe Serena
-
Form 3 Retension Pharmaceutical For: Oct 08 Filed by: Olds Donald
-
Form 3 Retension Pharmaceutical For: Oct 08 Filed by: Keller Eric L.
-
Form 4 MGM Resorts Internationa For: Oct 07 Filed by: Meinert Todd
-
Form 3 Retension Pharmaceutical For: Oct 08 Filed by: Bisson Sabine
-
Form 4 FB Financial Corp For: Oct 01 Filed by: HICKMAN MARK
-
Form 3 Retension Pharmaceutical For: Oct 08 Filed by: BERGER FRANKLIN M
-
Form 3 Retension Pharmaceutical For: Oct 08 Filed by: BERENDT MICHAEL J
-
Form 4 MGM Resorts Internationa For: Oct 07 Filed by: Molino Ayesha Khanna
-
Form 4 LENNAR CORP /NEW/ For: Oct 07 Filed by: Gilliam Theron I
-
Form 4 FB Financial Corp For: Oct 01 Filed by: Mettee Michael M.
-
Form 4 FB Financial Corp For: Oct 01 Filed by: TANSIL SCOTT J.
-
Form 4 LENNAR CORP /NEW/ For: Oct 07 Filed by: McClure Teri P
-
Form 4 Newegg Commerce, Inc. For: Oct 06 Filed by: CHANG FRED FACHING
-
Form 4 Apple Inc. For: Oct 06 Filed by: Newstead Jennifer
-
Form 4 LENNAR CORP /NEW/ For: Oct 07 Filed by: Banse Amy
-
Form 4 InMed Pharmaceuticals For: Oct 06 Filed by: Schneeberger Daniel
-
Form SCHEDULE 13G/A vTv Therapeutics Inc. Filed by: MILLENNIUM MANAGEMENT LLC
-
Form SCHEDULE 13G/A COLLEGIUM PHARMACEUTICAL Filed by: INTEGRATED CORE STRATEGIES (US) LLC
-
Form 4/A Nakamoto Inc. For: Aug 21 Filed by: YUSKO MARK W
-
Form 4/A Nakamoto Inc. For: Aug 21 Filed by: Xethalis Gregory Elias
-
Form 4/A Nakamoto Inc. For: Aug 21 Filed by: McNulty Perianne Boring
-
Form 4/A Nakamoto Inc. For: Aug 27 Filed by: Gendron Teresa S
-
Form 4/A Nakamoto Inc. For: Aug 27 Filed by: Dalton John Merritt
-
Form 4/A Nakamoto Inc. For: Aug 21 Filed by: Blackburn Charles Phillip
-
Form 4 STUDIO CITY INTERNATIONA For: Oct 06 Filed by: Silver Point Capital, L.P.
-
Form 4 Arqit Quantum Inc. For: Oct 06 Filed by: Wilder Ben Simon
-
Form 4 Arqit Quantum Inc. For: Oct 06 Filed by: Nilan Nicholas William
-
Form 4 Arqit Quantum Inc. For: Oct 06 Filed by: Ritchie Garth
-
Form 4 Arqit Quantum Inc. For: Oct 06 Filed by: Willcocks Patrick
-
Form 4 Arqit Quantum Inc. For: Oct 06 Filed by: Feenan Paul
-
Form 4 Arqit Quantum Inc. For: Oct 06 Filed by: Leaver Andrew
-
Form 4 Snowflake Inc. For: Oct 07 Filed by: Dageville Benoit
-
Form 144 Kinetik Holdings Inc. Filed by: ISQ Global Fund II GP LLC
-
Form 4 IMMERSION CORP For: Oct 07 Filed by: Nader Elias
-
Form 4 Life360, Inc. For: Oct 06 Filed by: Haro Alex
-
Form 4 IMMERSION CORP For: Oct 07 Filed by: MARTIN WILLIAM C
-
Form 4 IMMERSION CORP For: Oct 07 Filed by: HOFFMAN EMILY
-
Form 4 IMMERSION CORP For: Oct 07 Filed by: Wasch Childress Frederick
